1. Pink Sheet

Bookends for Reform

 
• By Ramsey Baghdadi

The boundaries of the health care reform debate for 2009 are evident in a bipartisan coalition of four senators (two Democrats and two Republicans) who have identified some of the fundamental components of any successful reform effort. Moving the access point for primary care out of the emergency rooms is one of the fundamentals.

If you want to know the shape of health care reform that could emerge from Congress in the next session, a good place to start is with a quartet of senators: Rhode Island Democrat Sheldon Whitehouse, North Carolina Republican Richard Burr, Ohio Democrat Sherrod Brown, and Oklahoma Republican Tom Coburn.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Pink Sheet

Maybe In May: US FDA Calls Coming On Moderna Next-Gen COVID-19 Vaccine, AbbVie’s Big ADC Bet

 
• By Bridget Silverman

The 31 May goal date for Moderna’s next-generation COVID-19 vaccine looms over the month, but the US FDA's decision lineup includes three more novel agents, including AbbVie's Teliso-V antibody-drug conjugate, as well as supplemental indications like GSK's bid for Nucala in COPD.

UK MHRA Tackles Staff Burnout As It Eliminates Filings Backlog

 
• By Vibha Sharma

Efforts by the medicines regulator, the MHRA, to clear all backlogs relating to its statutory functions and maintaining predictable review timeframes have put pressure on its staff.

Why Successful Companies Are ‘Tough On Themselves’ When It Comes To HTA

 
• By Eliza Slawther

Pharmaceutical companies need to “pressure test” their clinical development strategies early for health technology assessment purposes, particularly in light of the new EU HTA Regulation, a life sciences consultant says.